What is the STOP-BANG Questionnaire?
The STOP-BANG questionnaire is a validated screening tool developed by Dr. Frances Chung and colleagues at the University of Toronto. Originally designed for preoperative screening of surgical patients, it has become one of the most widely used tools for identifying patients at risk for obstructive sleep apnea (OSA) in both surgical and general clinical settings.
The acronym STOP-BANG stands for the eight screening criteria: Snoring, Tiredness, Observed apnea, Pressure (hypertension), BMI, Age, Neck circumference, and Gender. Each criterion is scored as yes (1) or no (0), giving a total score from 0 to 8.
The questionnaire has been validated in numerous studies and has high sensitivity for detecting moderate-to-severe OSA (sensitivity 93–100% for AHI ≥15 at a cutoff score of ≥3), making it an excellent screening tool to determine who should undergo formal sleep testing.
Scoring and Interpretation
| Score | Risk Category | Interpretation |
|---|---|---|
| 0–2 | Low Risk | Low probability of moderate-to-severe OSA |
| 3–4 | Intermediate Risk | Increased probability of OSA; consider sleep study |
| 5–8 | High Risk | High probability of moderate-to-severe OSA; sleep study recommended |
Additionally, a patient is considered at high risk for moderate-to-severe OSA if any of the following criteria are met:
- STOP-BANG score ≥5
- Score ≥2 plus male gender
- Score ≥2 plus BMI >35 kg/m²
- Score ≥2 plus neck circumference >40 cm
Understanding Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a common sleep disorder characterized by repeated episodes of partial or complete upper airway obstruction during sleep. These episodes lead to reductions (hypopneas) or complete cessation (apneas) of airflow despite ongoing respiratory effort, resulting in intermittent hypoxemia (low blood oxygen) and sleep fragmentation.
OSA severity is classified by the Apnea-Hypopnea Index (AHI), which measures the number of apneas and hypopneas per hour of sleep:
| AHI (events/hour) | Severity |
|---|---|
| < 5 | Normal |
| 5–14 | Mild OSA |
| 15–29 | Moderate OSA |
| ≥ 30 | Severe OSA |
OSA affects an estimated 10–30% of adults, though many remain undiagnosed. Prevalence increases with age, male sex, and obesity. It is estimated that 80–90% of people with moderate-to-severe OSA are undiagnosed.
Diagnosis: Sleep Studies
The gold standard for diagnosing OSA is an overnight polysomnography (PSG), conducted in a sleep laboratory. During a PSG, multiple physiological parameters are recorded:
- Brain activity (EEG) to determine sleep stages
- Eye movements (EOG) and muscle activity (EMG)
- Heart rhythm (ECG)
- Airflow through the nose and mouth
- Respiratory effort (chest and abdominal movement)
- Blood oxygen saturation (pulse oximetry)
- Body position and limb movements
Home sleep apnea tests (HSAT) are increasingly used as a more convenient and cost-effective alternative for patients with a high pre-test probability of moderate-to-severe OSA without significant comorbidities. HSATs typically measure airflow, respiratory effort, and oxygen saturation but do not measure brain activity, so they cannot determine sleep stages.
Treatment Options
- CPAP (Continuous Positive Airway Pressure): The first-line treatment for moderate-to-severe OSA. Delivers pressurized air through a mask to keep the airway open
- Oral appliances: Custom-made mandibular advancement devices that hold the jaw forward; effective for mild-to-moderate OSA
- Positional therapy: For patients whose OSA is predominantly positional (worse when supine)
- Weight loss: Even modest weight loss (10–15%) can significantly reduce AHI in overweight patients
- Surgery: Various procedures (UPPP, tonsillectomy, maxillomandibular advancement) for selected patients who cannot tolerate CPAP
- Hypoglossal nerve stimulation: Implantable device that stimulates the tongue muscles during sleep (for CPAP-intolerant patients)
- Lifestyle modifications: Avoiding alcohol, sedatives, and sleeping on the back
CPAP Therapy
CPAP remains the gold standard treatment for OSA. It works by delivering continuous positive air pressure through a nasal or full-face mask, creating a pneumatic splint that prevents airway collapse during sleep.
Benefits of consistent CPAP use include:
- Elimination of apneas and snoring
- Improved sleep quality and daytime alertness
- Reduced cardiovascular risk (blood pressure reduction of 2–7 mmHg)
- Improved mood and cognitive function
- Reduced motor vehicle accident risk
The main challenge with CPAP is adherence. Studies show that 30–50% of patients struggle with consistent use. Modern auto-titrating CPAP (APAP) machines, heated humidifiers, various mask options, and patient support programs have improved compliance rates. Adequate usage is generally defined as at least 4 hours per night for at least 70% of nights.
Health Consequences of Untreated OSA
Untreated OSA is associated with significant health consequences across multiple organ systems:
| System | Consequences |
|---|---|
| Cardiovascular | Hypertension (2–3x risk), atrial fibrillation, heart failure, coronary artery disease, stroke |
| Metabolic | Insulin resistance, type 2 diabetes, metabolic syndrome, weight gain |
| Neurological | Excessive daytime sleepiness, cognitive impairment, memory problems, depression |
| Safety | 2–3x increased motor vehicle accident risk, occupational injuries |
| Quality of Life | Impaired relationships (snoring), reduced productivity, sexual dysfunction |
| Perioperative | Increased risk of postoperative complications, difficult intubation, respiratory failure |
Frequently Asked Questions
How reliable is the STOP-BANG questionnaire?
The STOP-BANG questionnaire has excellent sensitivity (93–100%) for moderate-to-severe OSA at a score cutoff of ≥3, meaning it rarely misses significant cases. However, its specificity is moderate (about 43%), meaning some people flagged as high risk may not actually have OSA. A positive STOP-BANG screen should be followed by a formal sleep study for definitive diagnosis.
Can children have sleep apnea?
Yes, but the STOP-BANG questionnaire is designed for adults. Childhood OSA has different risk factors (enlarged tonsils/adenoids being the most common) and requires different screening tools and diagnostic criteria. Pediatric OSA affects 1–5% of children.
Is snoring always a sign of sleep apnea?
No. While loud, habitual snoring is the most common symptom of OSA, not all snorers have sleep apnea. Conversely, some people with OSA (particularly women and lean individuals) may not snore prominently. Simple snoring without apneic events is called "primary snoring" and, while annoying, does not carry the same health risks as OSA.
Can sleep apnea be cured?
OSA can sometimes be effectively resolved through weight loss (particularly in those whose OSA is primarily weight-related), surgical correction of anatomical abnormalities, or dental appliances. However, for many patients, OSA is a chronic condition requiring ongoing management with CPAP or other therapies. Significant weight loss (such as after bariatric surgery) can cure OSA in some patients.
What is the difference between OSA and central sleep apnea?
In OSA, breathing stops because the airway physically collapses. In central sleep apnea (CSA), breathing stops because the brain fails to send the proper signals to the breathing muscles. CSA is less common and associated with heart failure, stroke, and opioid use. Some patients have mixed (complex) sleep apnea with features of both. The STOP-BANG questionnaire is designed to screen for OSA specifically.